Pluribus Labs’s Insulet PODD Stock Holding History

Pluribus Labs’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,069	Closed	-$284K	–	181
2021 Q4	$284K	Buy	+1,069	New	+$310K	0.3%	141

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

Pluribus Labs's PODD Position: Q1 2022 in Review

Pluribus Labs sold out of Insulet (PODD) in Q1 2022, closing a stake of 1,069 shares — an estimated $284K sold.

Pluribus Labs first reported a position in PODD in Q4 2021 and held it in 1 quarter. The position peaked at $284K in Q4 2021. 482 funds tracked by Wall St. Rank hold PODD as of Q1 2022.

Pluribus Labs reported no remaining Insulet position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 1,069 Insulet shares in Q1 2022, an estimated $284K.
Pluribus Labs first reported a position in Insulet in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Insulet position peaked at $284K in Q4 2021.
482 funds tracked by Wall St. Rank held Insulet as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.